Seven-year follow-up analysis of adjuvant paclitaxel and trastuzumab trial for node-negative, human epidermal growth factor receptor 2-positive breast cancer Journal Article


Authors: Tolaney, S. M.; Guo, H.; Pernas, S.; Barry, W. T.; Dillon, D. A.; Ritterhouse, L.; Schneider, B. P.; Shen, F.; Fuhrman, K.; Baltay, M.; Dang, C. T.; Yardley, D. A.; Moy, B.; Marcom, P. K.; Albain, K. S.; Rugo, H. S.; Ellis, M. J.; Shapira, I.; Wolff, A. C.; Carey, L. A.; Overmoyer, B.; Partridge, A. H.; Hudis, C. A.; Krop, I. E.; Burstein, H. J.; Winer, E. P.
Article Title: Seven-year follow-up analysis of adjuvant paclitaxel and trastuzumab trial for node-negative, human epidermal growth factor receptor 2-positive breast cancer
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 22
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-08-01
Start Page: 1868
End Page: 1875
Language: English
ACCESSION: 137778947
DOI: 10.1200/jco.19.00066
PROVIDER: EBSCOhost
PROVIDER: cin20
PUBMED: 30939096
DOI/URL:
Notes: Accession Number: 137778947 -- Entry Date: In Process -- Revision Date: 20190731 -- Publication Type: Article -- Journal Subset: Biomedical; Editorial Board Reviewed; Expert Peer Reviewed; Peer Reviewed; USA -- NLM UID: 8309333. -- Source: cin20
Altmetric Score
MSK Authors
  1. Clifford Hudis
    861 Hudis
  2. Chau Dang
    170 Dang